Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash Flows from Operating Activities:
Net income	$ 1,772	$ 385
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	525	279
Provision for bad debts	175	176
Stock issued for costs and expenses	104	76
Compensatory element of stock issuances	0	112
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	66	(221)
Notes receivable	14
Costs and estimated earnings in excess of billings on uncompleted contracts	(387)	(947)
Inventories	(1,417)	291
Prepaid expenses and other current assets	(73)	37
Other assets	(14)	(7)
Advances and notes to related medical practices		41
Increase (decrease) in operating liabilities, net:
Accounts payable	(67)	(338)
Other current liabilities	727	1,463
Customer advances	(1,208)	552
Billings in excess of costs and estimated earnings on uncompleted contracts	813	(1,451)
Other liabilities	(4)	10
Due to related medical practices	2	(300)
Net cash provided by operating activities	1,028	158
Cash Flows from Investing Activities:
Purchases of property and equipment	(116)
Costs of capitalized software development		(24)
Cost of patents	(39)	(27)
Net cash used in investing activities	(155)	(51)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(326)	(155)
Distributions to non controlling interests	(288)
Repayment of notes receivable from employee stockholders	2	2
Net cash used in financing activities	(612)	(153)
Net Increase (Decrease) in Cash and Cash Equivalents	261	(46)
Cash and Cash Equivalents - Beginning of Period	9,251	1,299
Cash and Cash Equivalents - End of Period	$ 9,512	$ 1,253